<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SPI-23574</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">BioChina Project</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">IFC is considering an equity commitment of up to $5 million to the BioVeda China Fund (the fund or BioChina), an investment vehicle to be established by a select group of institutional investors, to invest in Chinese biotech and life sciences companies.  The Fund will be managed by BioVeda Capital (the manager or BioVeda), a Singapore/US headquartered biotech investment firm which currently manages a $32 million venture fund that has invested in the US and Asia.  The fund is targeting a first closing in early 2005.  BioChina targets to raise up to $25 million to be invested in 3-5 companies to whom the fund would provide both expansion capital and management expertise in order to help to grow their businesses significantly.  Exits are expected to be achieved through a stock exchange listing or a strategic sale.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN"></narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">BIOVEDA CHINA FUND II, LP</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SPI-23574" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2005-05-10" type="1"></activity-date>
  <activity-date iso-date="2005-06-28" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Mr. Damien Lim, General Partner   BioVeda Capital   Phone: (65) 6238-9200   Fax: (65) 6733-3832   E-mail:    damien@Biovedacapital.com</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN"></narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="CN" percentage="100">
   <narrative xml:lang="EN">China</narrative>
  </recipient-country>
  <location ref="CN-China">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">The main legal entity for the fund would be a Cayman Islands limited partnership.  The primary geographic focus of the investments would be China.  The investment team would operate primarily out of China.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>35.0000000000 105.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">BA - Private Equity/Venture Cap Fund - Country</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $5.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="510"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2005-05-10"></period-start>
   <period-end iso-date="2005-06-30"></period-end>
   <value currency="USD" value-date="2005-05-10">5000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2005-05-10"></transaction-date>
   <value currency="USD" value-date="2005-05-10">5000000</value>
   <receiver-org>
    <narrative xml:lang="EN">BIOVEDA CHINA FUND II, LP</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="510"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SPI/23574/biochina-project">
   <title>
    <narrative xml:lang="EN">Summary of Project Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
